These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34927207)

  • 41. Unique clinical and autoantibody profile of a large Asian Indian cohort of scleroderma-do South Asians have a more aggressive disease?
    Janardana R; Nair AM; Surin AK; Prakash JAJ; Gowri M; Danda D
    Clin Rheumatol; 2019 Nov; 38(11):3179-3187. PubMed ID: 31309339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.
    Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry.
    Marí-Alfonso B; Simeón-Aznar CP; Guillén-Del Castillo A; Rubio-Rivas M; Trapiella-Martínez L; Todolí-Parra JA; Rodríguez Carballeira M; Marín-Ballvé A; Iniesta-Arandia N; Colunga-Argüelles D; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas Hitos JA; Chamorro AJ; Madroñero-Vuelta AB; Perales-Fraile I; Pla-Salas X; Fernández-De-La-Puebla RA; Fonollosa-Pla V; Tolosa-Vilella C; ;
    Semin Arthritis Rheum; 2018 Jun; 47(6):849-857. PubMed ID: 29246416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.
    Fairley JL; Hansen D; Proudman S; Sahhar J; Ngian GS; Walker J; Strickland G; Wilson M; Morrisroe K; Ferdowsi N; Major G; Roddy J; Stevens W; Nikpour M;
    Arthritis Care Res (Hoboken); 2021 May; 73(5):732-741. PubMed ID: 32058672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of sicca symptoms in a South Australian cohort with systemic sclerosis.
    Swaminathan S; Goldblatt F; Dugar M; Gordon TP; Roberts-Thomson PJ;
    Intern Med J; 2008 Dec; 38(12):897-903. PubMed ID: 18422567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
    Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
    Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.
    Showalter K; Hoffmann A; Rouleau G; Aaby D; Lee J; Richardson C; Dematte J; Agrawal R; Chang RW; Hinchcliff M
    J Rheumatol; 2018 Nov; 45(11):1572-1576. PubMed ID: 30275265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting Sjögren's syndrome in patients with recent-onset SLE.
    Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
    Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients.
    Avouac J; Sordet C; Depinay C; Ardizonne M; Vacher-Lavenu MC; Sibilia J; Kahan A; Allanore Y
    Arthritis Rheum; 2006 Jul; 54(7):2243-9. PubMed ID: 16802363
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjögren's syndrome.
    Hebbar M; Lassalle P; Delneste Y; Hatron PY; Devulder B; Tonnel AB; Janin A
    Ann Rheum Dis; 1997 Apr; 56(4):230-4. PubMed ID: 9165994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing the quality of forced vital capacity measurement in patients with systemic sclerosis.
    Uzun GS; Sarı A; Karcıoğlu O; Sancar EN; Unaldı E; Fırlatan B; Bayram GS; Kılıç L; Akdoğan A
    Semin Arthritis Rheum; 2024 Aug; 67():152466. PubMed ID: 38823336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature.
    Pokeerbux MR; Giovannelli J; Dauchet L; Mouthon L; Agard C; Lega JC; Allanore Y; Jego P; Bienvenu B; Berthier S; Mekinian A; Hachulla E; Launay D
    Arthritis Res Ther; 2019 Apr; 21(1):86. PubMed ID: 30944015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sialographic study in patients with and without antibodies to Sjögren's syndrome A (Ro).
    Miyachi K; Naito M; Maeno Y; Suzuki S; Hamamoto T; Sugiura M; Kasahara M; Torikai K; Umeda H
    J Rheumatol; 1983 Jun; 10(3):387-94. PubMed ID: 6604159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Sjögren's syndrome in systemic scleroderma].
    Guseva NG; Simonova MV; Kirtava ZZ; Shcherbakov AB
    Ter Arkh; 1988; 60(4):54-6. PubMed ID: 3394099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score.
    Kuwana M; Allanore Y; Denton CP; Distler JHW; Steen V; Khanna D; Matucci-Cerinic M; Mayes MD; Volkmann ER; Miede C; Gahlemann M; Quaresma M; Alves M; Distler O
    Arthritis Rheumatol; 2022 Mar; 74(3):518-526. PubMed ID: 34514739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between disease characteristics and orofacial manifestations in systemic sclerosis: Canadian Systemic Sclerosis Oral Health Study III.
    Baron M; Hudson M; Tatibouet S; Steele R; Lo E; Gravel S; Gyger G; El Sayegh T; Pope J; Fontaine A; Masetto A; Matthews D; Sutton E; Thie N; Jones N; Copete M; Kolbinson D; Markland J; Nogueira G; Robinson D; Fritzler M; Gornitsky M
    Arthritis Care Res (Hoboken); 2015 May; 67(5):681-90. PubMed ID: 25303223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is extra-glandular organ damage in primary Sjögren's syndrome related to the presence of systemic auto-antibodies and/or hypergammaglobulinemia? A long-term cohort study with 110 patients from the Netherlands.
    Ter Borg EJ; Kelder JC
    Int J Rheum Dis; 2017 Jul; 20(7):875-881. PubMed ID: 28447402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Sjögren's syndrome with juvenile onset].
    Kaleda MI; Nikishina IP; Latypova AN
    Ter Arkh; 2019 May; 91(5):54-60. PubMed ID: 32598677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.